Therapeutic implications of GIPC1 silencing in cancer

Thomas W. Chittenden, Jane Pak, Renee Rubio, Hailing Cheng, Kristina Holton, Niall Prendergast, Vladimir Glinskii, Yi Cai, Aedin Culhane, Stefan Bentink, Mathew Schwede, Jessica C. Mar, Eleanor A. Howe, Martin Aryee, Razvan Sultana, Anthony A. Lanahan, Jennifer M. Taylor, Chris Holmes, William C. Hahn, Jean J. ZhaoJ. Dirk Iglehart, John Quackenbush

Research output: Contribution to journalArticle

15 Scopus citations
Original languageEnglish (US)
Article numbere15581
JournalPloS one
Volume5
Issue number12
DOIs
StatePublished - Dec 1 2010

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)
  • General

Cite this

Chittenden, T. W., Pak, J., Rubio, R., Cheng, H., Holton, K., Prendergast, N., Glinskii, V., Cai, Y., Culhane, A., Bentink, S., Schwede, M., Mar, J. C., Howe, E. A., Aryee, M., Sultana, R., Lanahan, A. A., Taylor, J. M., Holmes, C., Hahn, W. C., ... Quackenbush, J. (2010). Therapeutic implications of GIPC1 silencing in cancer. PloS one, 5(12), [e15581]. https://doi.org/10.1371/journal.pone.0015581